Megan E. Cavanaugh
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Peptidase Inhibition and Analysis 2
-
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Patrick H. Lizotte (6 shared papers)Turner Osler (1 shared paper)Neil Hyman (1 shared paper)Jochen H. Lorch (2 shared papers)Glenn J. Hanna (2 shared papers)Jonathan D. Schoenfeld (2 shared papers)Ravindra Uppaluri (2 shared papers)Nicole G. Chau (2 shared papers)
- Journals
- Frontiers in Oncology (1 paper)Journal of Clinical Oncology (1 paper)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (1 paper)Oral Oncology (1 paper)Diseases of the Colon & Rectum (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Megan E. Cavanaugh
10 papers receiving 481 citations
Peers
Comparison fields: 5 of 64
- Otorhinolaryngology 54
- Oncology 317
- Immunology 104
- Rheumatology 64
- Cancer Research 50
Countries citing papers authored by Megan E. Cavanaugh
This map shows the geographic impact of Megan E. Cavanaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Cavanaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Cavanaugh more than expected).
Fields of papers citing papers by Megan E. Cavanaugh
This network shows the impact of papers produced by Megan E. Cavanaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Cavanaugh. The network helps show where Megan E. Cavanaugh may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan E. Cavanaugh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 200 | |
| 2 | 2002 | 81 | |
| 3 | 2018 | 69 | |
| 4 | 2017 | 40 | |
| 5 | 2010 | 34 | |
| 6 | 2021 | 33 | |
| 7 | 1999 | 18 | |
| 8 | 2017 | 8 | |
| 9 | 2018 | 4 | |
| 10 | 2024 | 1 |
About Megan E. Cavanaugh
Megan E. Cavanaugh is a scholar working on Oncology, Molecular Biology, Surgery, Biotechnology and Biomedical Engineering, having authored 10 papers that have together received 488 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers), CAR-T cell therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Pelvic floor disorders treatments (1 paper), Occupational and environmental lung diseases (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Otorhinolaryngology (54 citations), Oncology (317 citations), Immunology (104 citations), Rheumatology (64 citations) and Cancer Research (50 citations). Megan E. Cavanaugh has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Patrick H. Lizotte, Turner Osler, Neil Hyman, Jochen H. Lorch, Glenn J. Hanna, Jonathan D. Schoenfeld, Ravindra Uppaluri, Nicole G. Chau, Robert I. Haddad and Frank C. Kuo. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Oral Oncology and Diseases of the Colon & Rectum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.